Literature DB >> 2223704

Haemorheological changes in patients with retinal vein occlusion after isovolaemic haemodilution.

J Wiek1, M Schade, M Wiederholt, H R Arntz, L L Hansen.   

Abstract

In 83 patients with central retinal vein occlusion and branch vein occlusion we measured the haematocrit (HCT), plasma viscosity (PV), red cell aggregation (RCA), red cell filterability (RCF) and apparent whole blood viscosity (WBV). A control group (n = 41) was matched for sex, age, and cardiovascular risk factors. Measurements were performed before and after treatment with isovolaemic haemodilution (IHD). We found no significant differences between patients with retinal vein occlusion (RVO) and control subjects in haematocrit, plasma viscosity, red cell aggregation, and red cell filterability and no increased whole blood viscosity in the patient group. Patients with ischaemic retinal vein occlusion and non-ischaemic retinal vein occlusion did not show different haemorheological parameters either. After treatment with haemodilution, only the haematocrit and whole blood viscosity were significantly decreased, and there were no changes in plasma viscosity, red cell aggregation or red cell filterability.

Entities:  

Mesh:

Year:  1990        PMID: 2223704      PMCID: PMC1042254          DOI: 10.1136/bjo.74.11.665

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  17 in total

1.  A simple method for measuring erythrocyte deformability.

Authors:  H L Reid; A J Barnes; P J Lock; J A Dormandy; T L Dormandy
Journal:  J Clin Pathol       Date:  1976-09       Impact factor: 3.411

Review 2.  Androgens and erythropoiesis.

Authors:  N T Shahidi
Journal:  N Engl J Med       Date:  1973-07-12       Impact factor: 91.245

3.  [Whole blood- and plasma viscosity in the presence of coronary risk factors. Investigations concerning the characteristics of blood flow and viscosity-effective plasma components in patients with coronary risk factors and risk factor combinations (author's transl)].

Authors:  H Leonhardt; A Uthoff; C Uthoff
Journal:  Klin Wochenschr       Date:  1977-05-15

4.  Systemic factors contributory to retinal vein occlusion.

Authors:  M A McGrath; F Wechsler; A B Hunyor; R Penny
Journal:  Arch Intern Med       Date:  1978-02

5.  [The mini-erythrocyte aggregometer: a new apparatus for the rapid quantification of the extent of erythrocyte aggregation].

Authors:  H Kiesewetter; H Radtke; R Schneider; K Mussler; A Scheffler; H Schmid-Schönbein
Journal:  Biomed Tech (Berl)       Date:  1982-09       Impact factor: 1.411

6.  Viscosity and retinal vein thrombosis.

Authors:  C P Ring; T C Pearson; M D Sanders; G Wetherley-Mein
Journal:  Br J Ophthalmol       Date:  1976-06       Impact factor: 4.638

7.  [Treatment of central retinal venous and arterial occlusion by isovolemic hemodilution (author's transl)].

Authors:  M Wiederholt; H Leonhardt; H Schmid-Schönbein; H Hager
Journal:  Klin Monbl Augenheilkd       Date:  1980       Impact factor: 0.700

8.  Retinal vein occlusion and the prevalence of lipoprotein abnormalities.

Authors:  P M Dodson; D J Galton; A M Hamilton; R K Blach
Journal:  Br J Ophthalmol       Date:  1982-03       Impact factor: 4.638

9.  Abnormal blood viscosity and haemostasis in long-standing retinal vein occlusion.

Authors:  G E Trope; G D Lowe; B M McArdle; J T Douglas; C D Forbes; C M Prentice; W S Foulds
Journal:  Br J Ophthalmol       Date:  1983-03       Impact factor: 4.638

10.  Direct relationship between blood pressure and blood viscosity in normal and hypertensive subjects. Role of fibrinogen and concentration.

Authors:  R L Letcher; S Chien; T G Pickering; J E Sealey; J H Laragh
Journal:  Am J Med       Date:  1981-06       Impact factor: 4.965

View more
  10 in total

Review 1.  Central retinal vein occlusion: what's the story?

Authors:  T H Williamson
Journal:  Br J Ophthalmol       Date:  1997-08       Impact factor: 4.638

2.  Haemorheology in patients with branch retinal vein occlusion with and without risk factors.

Authors:  A Remky; O Arend; F Jung; H Kiesewetter; M Reim; S Wolf
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-08       Impact factor: 3.117

3.  Influence of age, systemic blood pressure, smoking, and blood viscosity on orbital blood velocities.

Authors:  T H Williamson; G D Lowe; G M Baxter
Journal:  Br J Ophthalmol       Date:  1995-01       Impact factor: 4.638

4.  Hypercoagulable states in patients with retinal venous occlusion.

Authors:  A M Abu El-Asrar; A G Abdel Gader; S Al-Amro; A K Al-Momen
Journal:  Doc Ophthalmol       Date:  1998       Impact factor: 2.379

5.  Blood viscosity, coagulation, and activated protein C resistance in central retinal vein occlusion: a population controlled study.

Authors:  T H Williamson; A Rumley; G D Lowe
Journal:  Br J Ophthalmol       Date:  1996-03       Impact factor: 4.638

6.  Hemodilution therapy using automated erythrocytapheresis in central retinal vein occlusion: results of a multicenter randomized controlled study.

Authors:  Agnès Glacet-Bernard; Marielle Atassi; Christine Fardeau; Jean-Paul Romanet; Matthieu Tonini; John Conrath; Philippe Denis; Martine Mauget-Faÿsse; Gabriel Coscas; Gisèle Soubrane; Eric Souied
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-10-17       Impact factor: 3.117

7.  Haemorheological parameters in patients with retinal artery occlusion and anterior ischaemic optic neuropathy.

Authors:  J Wiek; M Krause; M Schade; M Wiederholt; L L Hansen
Journal:  Br J Ophthalmol       Date:  1992-03       Impact factor: 4.638

8.  Intravitreous bevacizumab in the treatment of macular edema from branch retinal vein occlusion and hemisphere retinal vein occlusion (an AOS thesis).

Authors:  Gary Edd Fish
Journal:  Trans Am Ophthalmol Soc       Date:  2008

9.  Hemodilution therapy in central retinal vein occlusion. One-year results of a prospective randomized study.

Authors:  S Wolf; O Arend; B Bertram; A Remky; K Schulte; K J Wald; M Reim
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1994-01       Impact factor: 3.117

10.  Bilateral Central Retinal Vein Occlusion, multiple dental implants and severe glomerulonephtitis - Any connection?

Authors:  Monica Malaescu; Bogdana Tabacaru; Simona Stanca; Tudor Horia Stanca
Journal:  Rom J Ophthalmol       Date:  2019 Jul-Sep
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.